NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/07/2023
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
ALACRITA
ST13
US500000085557129Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Jeff Goehring Nixon & Vanderhye P.C.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business and market research; business analysis, business planning, business management and business strategy, namely, strategic planning services, strategy development services and business consultancy in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; business advice regarding the development and commercialization of products in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; recruitment and personnel services, namely, personnel placement; tax services, namely, tax consultation and accountancy services; advertising and promotional services; arranging business networking meeting opportunities for businesses to meet potential investors and to promote their products; information, consultancy and advice relating to any of the aforesaid services; management of clinical trials for drugs, vaccines, diagnostic reagents, small molecules, medical devices, namely, providing information management services, providing clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and application for drug approval, or providing independent reviews of clinical trials for business purposes; preparation of reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, and medical devices, namely, providing information, management and compilation of computerized databases in the field of clinical trials for business purposes; preparing technical business or financial reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, medical devices, preparation of reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, and medical devices
Classe 36
Financial advice for companies in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; arranging funding, namely, providing financing services, investment consultancy; information, consultancy and advice relating to any of the aforesaid services
Classe 42
Research in the field of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and scientific research in the field of healthcare industries; clinical research, namely, managing clinical trials for others, providing medical and scientific research information in the field of clinical trials; testing of pharmaceuticals, diagnostic reagents or medical products; conducting of clinical trials for others for drugs, vaccines, diagnostic reagents, small molecules, medical devices; providing scientific information, namely, preparation of reports on clinical trials of drugs, vaccines, diagnostics, small molecules, cellular therapies, medical devices, and research reagents; scientific research, namely, writing of medical research and scientific research-related documents and preparing reports on medical research and scientific research-related documents; testing the safety of pharmaceuticals, vaccines, diagnostic reagents, small molecules, cellular therapies, and medical devices, and information, consultancy and advice relating to any of the aforesaid services; consultancy, advice and information in the field of development of drugs, vaccines, diagnostic reagents, small molecules, and medical devices
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/07/2023
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
30/06/2023
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
30/06/2023
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/06/2023
TEAS SECTION 8 & 9 RECEIVED
06/12/2022
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/12/2021
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/11/2020
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/11/2020
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15/11/2020
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/11/2020
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/11/2020
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/11/2020
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/12/2018
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/12/2018
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2018
TEAS SECTION 8 RECEIVED
03/12/2018
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/12/2017
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
24/05/2017
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/03/2014
REGISTERED-PRINCIPAL REGISTER
11/12/2012
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/09/2012
PUBLISHED FOR OPPOSITION
25/09/2012
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/09/2012
LAW OFFICE PUBLICATION REVIEW COMPLETED
22/08/2012
APPROVED FOR PUB - PRINCIPAL REGISTER
22/08/2012
EXAMINER'S AMENDMENT ENTERED
22/08/2012
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/08/2012
EXAMINERS AMENDMENT E-MAILED
22/08/2012
EXAMINERS AMENDMENT -WRITTEN
22/08/2012
AMENDMENT FROM APPLICANT ENTERED
16/08/2012
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/08/2012
FAX RECEIVED
14/08/2012
NOTIFICATION OF FINAL REFUSAL EMAILED
31/07/2012
FINAL REFUSAL E-MAILED
31/07/2012
FINAL REFUSAL WRITTEN
31/07/2012
AMENDMENT FROM APPLICANT ENTERED
12/07/2012
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2012
ASSIGNED TO LIE
12/07/2012
FAX RECEIVED
02/07/2012
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/06/2012
NON-FINAL ACTION E-MAILED
19/06/2012
NON-FINAL ACTION WRITTEN
19/06/2012
ASSIGNED TO EXAMINER
12/06/2012
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2012
NEW APPLICATION ENTERED
05/03/2012
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.